Beyond Receptor Tyrosine Kinase Alterations: Dynamic Dependency in Tumor Evolution and Therapeutic Resistance
Cancers · 14.11.2026 · 18 (22) · 3647
DOI: 10.3390/cancers18223647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 14.11.2026. Verfasst von Randa A. Abdelnaser und 3 weiteren Autor:innen. Die Arbeit nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Umm Al-Qura University.
Abstract (Originalsprache)
Receptor tyrosine kinase (RTK) signaling is a major driver of oncogenesis and an important target in precision oncology. However, the presence of an oncogenic RTK alteration does not necessarily confer sustained functional dependency on the affected receptor or predict a durable therapeutic response. RTK-targeted therapy can trigger early adaptive signaling responses and, under continued therapeutic selection pressure, promote acquired resistance through compensatory pathway activation, secondary genetic alterations, phenotypic plasticity, and metabolic reprogramming. These processes are further shaped by receptor trafficking, intratumor heterogeneity, and the tumor microenvironment. Although individual resistance mechanisms are increasingly understood, their integration into a unified model of RTK dependency and tumor evolution remains incomplete. Here, we propose a multiscale framework integrating oncogenic alterations, functional signaling dependencies, and their evolution under therapeutic selection pressure. We examine how structural biology, functional genomics, multi-omics, and longitudinal biomarker profiling can characterize RTK activity, functional dependency and emerging vulnerabilities across molecular, cellular, and spatial contexts. We further discuss their potential to inform adaptive therapeutic strategies. This framework positions RTK dependency as a dynamic, context-dependent state rather than an invariant consequence of tumor genotype, highlighting the need to distinguish oncogenic driver status from functional dependency. Integrating genomic, functional, and longitudinal assessments may provide a basis for improved characterization of therapeutic response, evolving resistance, and emerging vulnerabilities in RTK-directed precision oncology.
Förderung
- Umm Al-Qura University
Zitieren
APA
Abdelnaser, R. A., Hamdy, A. K., Abourehab, M. A. S., & Bräse, S. (2026). Beyond Receptor Tyrosine Kinase Alterations: Dynamic Dependency in Tumor Evolution and Therapeutic Resistance. Cancers, 18(22), 3647. https://doi.org/10.3390/cancers18223647
Vancouver
Abdelnaser RA, Hamdy AK, Abourehab MAS, Bräse S. Beyond Receptor Tyrosine Kinase Alterations: Dynamic Dependency in Tumor Evolution and Therapeutic Resistance. Cancers. 2026;18(22):3647. doi:10.3390/cancers18223647
BibTeX
@article{Abdelnaser2026,
author = {Abdelnaser, Randa A. and Hamdy, Ahmed K. and Abourehab, Mohammed A. S. and Bräse, Stefan},
title = {Beyond Receptor Tyrosine Kinase Alterations: Dynamic Dependency in Tumor Evolution and Therapeutic Resistance},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3647},
doi = {10.3390/cancers18223647}
}
EUVIMED